Talk:Fractyl Health
Add topicAppearance
Latest comment: 1 year ago by MaryGaulke in topic Comments left during AfC process
| This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
|
Disclosing COI
[edit]Hi! Getting it on the record here that I, the author of the initial draft of this page, have a COI: Fractyl is a client of my employer, Porter Novelli. I'm happy to help with any feedback to ensure this article's neutrality and value. Thanks for your time. Mary Gaulke (talk) 15:11, 25 February 2025 (UTC)
Comments left during AfC process
[edit]
Comment: Article is promotional, and sourced almost entirely to announcements about its products, rather than about the company itself. Ref. 2 is probably fine, but the others are routine announcements and/or not about the company. Please tone down promotional content and emphasize secondary coverage of Fractyl (not its products) in reliable sources, ideally for a general audience (trade publications are fine but shouldn't form the backbone of the article). WeirdNAnnoyed (talk) 12:09, 4 March 2025 (UTC)
Comment: In addition to making some edits, listing what I believe is the most significant coverage of this org (also cited in the article) in case it's helpful in reviewing:
- Baxter, Amy (10 February 2025). "Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments". PharmaVoice. Retrieved 7 March 2025.
- DeFeudis, Nicole (16 June 2021). "After a decade in the type 2 diabetes game, Fractyl Laboratories recharges with a fresh $100M and a new name". Endpoints News. Archived from the original on 16 June 2021. Retrieved 10 January 2025.
- Fonseca, Camilo (18 January 2024). "Lexington-based Fractyl Health, focused on non-drug treatments for diabetes and obesity, filing for IPO". The Lexington Observer. Retrieved 9 January 2025.
- Lawrence, Stacy (14 October 2015). "FierceMedicalDevices' 2015 Fierce 15". Fierce Biotech. Retrieved 20 May 2025.
Thank you! Mary Gaulke (talk) 15:19, 20 May 2025 (UTC)
Categories:
- Start-Class AfC articles
- AfC submissions by date/18 July 2025
- Accepted AfC submissions
- Start-Class company articles
- Low-importance company articles
- WikiProject Companies articles
- Start-Class United States articles
- Low-importance United States articles
- Start-Class United States articles of Low-importance
- Start-Class Massachusetts articles
- Unknown-importance Massachusetts articles
- WikiProject Massachusetts articles
- WikiProject United States articles
- Start-Class medicine articles
- Low-importance medicine articles
- All WikiProject Medicine pages
- Talk pages of subject pages with paid contributions

